103346-16-3 Usage
General Description
3-Iodobenzylguanidinium sulfate is a chemical compound that is a guanidinium salt. It is composed of the 3-iodobenzylguanidinium cation and the sulfate anion. 3-Iodobenzylguanidinium-sulfate is a white crystalline powder that is highly soluble in water. It is commonly used in organic synthesis and as a reagent in chemical reactions. Additionally, it has been studied for its potential pharmaceutical applications, particularly as an antiviral agent. 3-Iodobenzylguanidinium sulfate is also known for its ability to form stable complexes with biological macromolecules, making it a valuable tool in biochemistry and molecular biology research.
Check Digit Verification of cas no
The CAS Registry Mumber 103346-16-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,3,4 and 6 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 103346-16:
(8*1)+(7*0)+(6*3)+(5*3)+(4*4)+(3*6)+(2*1)+(1*6)=83
83 % 10 = 3
So 103346-16-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H10IN3.H2O4S/c9-7-3-1-2-6(4-7)5-12-8(10)11;1-5(2,3)4/h1-4H,5H2,(H4,10,11,12);(H2,1,2,3,4)
103346-16-3Relevant articles and documents
Preparation method of meto-Iodobenzylguanidine
-
Paragraph 0032; 0033, (2017/02/17)
The invention relates to a preparation method of I-MIBG (meto-Iodobenzylguanidine). The method comprises the following steps: heating meto-Iodobenzylguanidine sulfate, stannous mono-sulphate, a reducing agent, copper sulfate and NaI in a boiling water bath, standing after finishing the reaction, taking a supernatant liquid, and filtering the supernatant liquid with a microfiltration membrane. Sodium thiosulfate and/or sodium thiosulfate are/is taken as the reducing agent to prepare the meto-Iodobenzylguanidine sulfate, the prepared I-MIBG is high in radiochemical purity and good in stability, and the radiochemical purity of the prepared I-MIBG is still at a relatively high level after 48 hours.
Imaging agent and method of use
-
, (2008/06/13)
A new radiopharmaceutical composition for use in nuclear medicine comprises a radioiodinated meta-iodobenzylguanidine. The composition is used as an imaging agent for the heart, adrenal medulla, and tumors of the adrenal medulla and can be used for treatm
